Literature DB >> 29885991

Interferon-γ interferes with host cell metabolism during intracellular Chlamydia trachomatis infection.

Kensuke Shima1, Nadja Kaeding2, Iretiolu Mayokun Ogunsulire2, Inga Kaufhold2, Matthias Klinger3, Jan Rupp4.   

Abstract

Interferon-γ (IFN-γ) is a central mediator of host immune responses including T-cell differentiation and activation of macrophages for the control of bacterial pathogens. Anti-bacterial mechanisms of IFN-γ against the obligate intracellular bacteria Chlamydiatrachomatis in epithelial cells have been intensively investigated in the past, focusing on cellular tryptophan depletion by an IFN-γ induced expression of the indoleamine 2, 3-deoxygenase (IDO). In this study, we could show that IFN-γ treatment caused a significant reduction of the host cell glycolysis that was accompanied by a reduction of glucose transporter-1 (GLUT1) and hypoxia inducible factor-1α (HIF-1α) expression. Furthermore, C. trachomatis induced enhancement of glycolytic and mitochondrial activation were significantly suppressed by IFN-γ treatment. We could further show that glucose starvation, as observed under IFN-γ treatment, was associated with an attenuated antimicrobial efficacy of doxycycline (DOX) against C. trachomatis. In conclusions, anti-chlamydial activity of IFN-γ goes beyond tryptophan depletion including interference with cellular energy metabolism resulting reduced progeny, but also impaired antimicrobial susceptibility of C. trachomatis.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial efficacy; C. trachomatis; GLUT1; Glycolysis; HIF-1α; IFN-γ; Mitochondria

Mesh:

Substances:

Year:  2018        PMID: 29885991     DOI: 10.1016/j.cyto.2018.05.039

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  6 in total

1.  Interferon-γ Impairs Human Coronary Artery Endothelial Glucose Metabolism by Tryptophan Catabolism and Activates Fatty Acid Oxidation.

Authors:  Laurel Yong-Hwa Lee; William M Oldham; Huamei He; Ruisheng Wang; Ryan Mulhern; Diane E Handy; Joseph Loscalzo
Journal:  Circulation       Date:  2021-10-12       Impact factor: 29.690

2.  Interferon-γ Possesses Anti-Microbial and Immunomodulatory Activity on a Chlamydia Trachomatis Infection Model of Primary Human Synovial Fibroblasts.

Authors:  Marisa Di Pietro; Simone Filardo; Federica Frasca; Carolina Scagnolari; Martina Manera; Vincenzo Sessa; Guido Antonelli; Rosa Sessa
Journal:  Microorganisms       Date:  2020-02-10

Review 3.  Persistence of Intracellular Bacterial Pathogens-With a Focus on the Metabolic Perspective.

Authors:  Wolfgang Eisenreich; Thomas Rudel; Jürgen Heesemann; Werner Goebel
Journal:  Front Cell Infect Microbiol       Date:  2021-01-14       Impact factor: 5.293

4.  Host cell response and distinct gene expression profiles at different stages of Chlamydia trachomatis infection reveals stage-specific biomarkers of infection.

Authors:  Emmanuel Enoch Dzakah; Liping Huang; Yaohua Xue; Shuai Wei; Xiaolin Wang; Hongliang Chen; Jingwei Shui; Foster Kyei; Farooq Rashid; Heping Zheng; Bing Yang; Shixing Tang
Journal:  BMC Microbiol       Date:  2021-01-04       Impact factor: 3.605

Review 5.  Chlamydia trachomatis as a Current Health Problem: Challenges and Opportunities.

Authors:  Rafaela Rodrigues; Carlos Sousa; Nuno Vale
Journal:  Diagnostics (Basel)       Date:  2022-07-25

6.  c-Myc plays a key role in IFN-γ-induced persistence of Chlamydia trachomatis.

Authors:  Karthika Rajeeve; Thomas Rudel; Nadine Vollmuth; Lisa Schlicker; Yongxia Guo; Pargev Hovhannisyan; Sudha Janaki-Raman; Naziia Kurmasheva; Werner Schmitz; Almut Schulze; Kathrin Stelzner
Journal:  Elife       Date:  2022-09-26       Impact factor: 8.713

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.